Prognostic and predictive values of transcriptomic signatures in metastatic pancreatic cancer: A biomarker analysis of three French multicenter prospective randomized controlled phase 2 trials (Prodige35, Prodige37 and AFUGEM).

Cancer LettJul 28, 2026 (epub)
Clinical ResearchOncology (Medical)

Shulin Zhao, Remy Nicolle, Julien Taieb et al.

✦ AI-curated · Sources linked

In 30 seconds

This study analyzed transcriptomic signatures in 178 patients with metastatic pancreatic cancer from three phase 2 trials. The immune classical subtype demonstrated superior median progression-free survival (PFS) of 9.03 months and overall survival (OS) of 11.27 months compared to other subtypes. The findings suggest that transcriptomic signatures can inform prognosis and treatment strategies.

Key findings

  • Immune classical subtype showed a median PFS of 9.03 months and OS of 11.27 months.
  • Higher classical component correlated with improved OS (HR=0.737, p=0.005).
  • Inactive stroma predicted better PFS (HR=0.66, p=0.003) and OS (HR=0.697, p=0.013).
  • GemPred-negative patients treated with FOLFIRINOX had longer PFS (8.2 vs. 2.3 months; HR=2.28, p=0.008).

Why it matters

Understanding the prognostic and predictive values of transcriptomic signatures can enhance treatment decision-making in metastatic pancreatic cancer, potentially leading to improved patient outcomes.

Source

PubMed · PMID 42521075

Published in Cancer Lett. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchPreventive Medicine / Public Health

2025 National Guidelines on the Mediterranean Diet: Executive Summary of a Joint Report by Italian Scientific Societies and the National Institute of Health Task Force on Clinical Practice Guidelines.

This systematic review and practice guideline, developed by a multidisciplinary panel using NUTRIGRADE, assessed Mediterranean diet evidence across nine health domains and one economic domain.

Nutr RevNov 12, 2026Read summary
Clinical ResearchOrthopedic Surgery

Prevention of Venous Thromboembolism after Total Hip or Knee Replacement.

This multicenter randomized comparative-effectiveness noninferiority trial compared 30 days of aspirin, warfarin, or rivaroxaban for VTE prophylaxis after elective total hip or knee arthroplasty.

N Engl J MedNov 12, 2026Read summary
Clinical ResearchAnesthesiology

Effect of discontinuing antihypertensives on perioperative hypotension in older patients before non-cardiac surgery: multicentre, randomised, double blind, controlled trial.

This multicentre, randomised, double blind, placebo controlled trial assessed whether withholding ACE inhibitors or ARBs on the morning of surgery reduces perioperative hypotension in older adults undergoing non-cardiac…

BMJNov 11, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.